About: A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Bengt Winblad et al published 2007 in International Journal of Geriatric Psychiatry

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2007 (uk) article scientifique publié en 2007 (fr) im Jahr 2007 veröffentlichter wissenschaftlicher Artikel (de) article by Bengt Winblad et al published 2007 in International Journal of Geriatric Psychiatry (en)
publication date	wds:Q56637378-ED18FF4E-5F73-4453-B7BA-60B0E7A15023
publication date	2007-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56637378-925CDCF4-CE98-4864-B652-708DB288BCB7
language of work or name	English
cites work	wds:Q56637378-08FBF4EB-C998-409B-9C21-CB301BDDC1B3 wds:Q56637378-1C96C0A8-9B4F-46F0-BB4F-39F2A23097DF wds:Q56637378-44708401-C951-4D42-B381-ABD0CE97C94C wds:Q56637378-5F63A895-D2BB-440F-9E16-296538E41E0D wds:Q56637378-654995E9-84E5-4237-A8E8-09A554F90F56 wds:Q56637378-7B0D61C2-AFA3-4267-891F-7F80CC15E74C wds:Q56637378-7E20F700-2126-4693-8A00-896B078E53B1 wds:Q56637378-8229A479-B5BA-40B6-B737-697B5DEB2504 wds:Q56637378-88491D33-8BFE-44F5-8508-6502E98EAACE wds:Q56637378-A7DCB293-7169-4517-AFC6-2D2131C5E3AD wds:Q56637378-B3E4D0CB-2433-4014-BBBA-77CF2795225D wds:Q56637378-E569B5F0-B217-466C-B45D-E85C90B60228 wds:Q56637378-EE8BA741-639F-4FDF-BE66-FAF1D7A6DE07 wds:Q56637378-FD11651C-3510-4346-843D-A62FBBC97321
cites work	Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors Selective loss of central cholinergic neurons in Alzheimer's disease A new rating scale for Alzheimer's disease. Clock completion: an objective screening test for dementia. Validity of the Trail Making Test as an Indicator of Organic Brain Damage The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus “Mini-mental state” Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education AD2000: donepezil in Alzheimer's disease Aggressive course of disease in dementia
author name string	wds:Q56637378-27C2751E-B219-4566-AA85-B5841ECFE122 wds:Q56637378-33BDC0C4-1D33-4F1C-8050-0054819E6842 wds:Q56637378-40DEAA75-EA4A-474D-A912-16670B6F3075 wds:Q56637378-454FBC8D-FFA4-4E0E-9D2F-92CB3646DDF6 wds:Q56637378-8F07E159-3478-4236-AF15-F6D225B22708 wds:Q56637378-B4031014-ED1B-4446-8483-6AFD69B67847 wds:Q56637378-EC6EA1AF-497A-4B9A-8977-0FF8E7FCCBE6
author name string	Niels Andreasen Marco Onofrj Roger Lane George Grossberg Jennifer Nagel Carl Sadowsky Stefanie Zechner
rdfs:label	A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (en) A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (nl)
skos:prefLabel	A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (en) A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (nl)
name	A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (en) A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (nl)
author	wds:Q56637378-3F7B5EFD-4804-4F37-91EB-47CFC14BF6DB wds:Q56637378-4733B407-01EC-4960-A44B-3CD1022A75AC
author	Bengt Winblad Jeffrey L. Cummings
title	wds:Q56637378-43A8FE52-2475-4398-9DBB-8B6DF2F68B65
title	A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule (en)
page(s)	wds:Q56637378-F8D36FCF-CB1A-40A1-A3E9-6DB47B805FB6
page(s)	456-467
instance of	wds:Q56637378-6F9C8993-2457-411E-8FA9-0F195FBE83F9
instance of	scholarly article
main subject	wds:Q56637378-6B3CDE65-E9CC-455D-A136-9EF3419F424D
main subject	placebo
PubMed ID	wds:Q56637378-F58B7302-72BB-409C-9AAF-210F8533487D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17380489
PubMed ID	17380489
published in	wds:Q56637378-954A4F3D-D7B8-4EB5-B8A5-4A96400EA903
published in	International Journal of Geriatric Psychiatry
issue	wds:Q56637378-ACFD9535-1DAF-44AF-9809-CABBDEB8346F
volume	wds:Q56637378-B8AA5B61-700A-45CD-BA3C-B839C15B99A2
issue	5
volume	22
DOI	wds:Q56637378-CABC33EF-3345-4146-8C55-BFA45DA3BF2B
DOI	http://dx.doi.org/10.1002/GPS.1788
DOI	10.1002/GPS.1788
ResearchGate publication ID	wds:Q56637378-0C1109C2-E48F-4071-9B98-E6585111EA50
ResearchGate publication ID	6427818
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56637378
is cites work of	Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model. The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis. Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer’s disease Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects Drug delivery strategies for Alzheimer's disease treatment. Donepezil in the treatment of patients with Alzheimer's disease Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software